KRAS is the most frequently mutated oncogene in solid tumors in general, and in lung tumors in particular. There are more patients whose lung tumors are driven by KRAS mutations than by ALK, Ros, Ret and TRK alterations. Combined. And after 40 years, they look to be getting a targeted therapy, or even two.
Keeping you up to date on recent developments in oncology, including: Less fractionation, fewer trips not a problem for some high-risk prostate cancers; PCOS passed on in the epigenes; Algorithm uses ultrasound images for classification.
Keeping you up to date on recent developments in cardiology, including: Radial access shows well in analysis of PCI data; ACC, SVS combine registries; VAD-associated ED visits down, but room for improvement.
The largest single cell transcriptomics study of neuroblastoma to date has discovered that this childhood cancer arises from a single type of embryonic cell, the sympathoblast.
Keeping you up to date on recent developments in neurology, including: Smartwatch sensors enable remote monitoring, treatment guidance for Parkinson’s patients; Imaging of a living brain can help differentiate dementia; Morphine itch comes from neurons, not mast cells.
Keeping you up to date on recent developments in diagnostics, including: A deep learning tool to predict cardiovascular risk; Smartphone-based COVID-19 test; PCOS passed on in the epigenes.
KRAS is the most frequently mutated oncogene in solid tumors in general, and in lung tumors in particular. There are more patients whose lung tumors are driven by KRAS mutations than by ALK, Ros, Ret and TRK alterations. Combined. And after 40 years, they look to be getting a targeted therapy, or even two.
RSS
